{
    "uniprot_canonical_ac": "A0A0G2JXM2-1",
    "uniprot_id": [
        {
            "id": "A0A0G2JXM2_RAT",
            "url": "https://www.uniprot.org/uniprot/A0A0G2JXM2_RAT",
            "type": "external"
        }
    ],
    "mass": 80578.0,
    "length": 724,
    "protein_name": "Cyclin-T1",
    "gene_name": "Ccnt1",
    "organism": "Rat",
    "refseq_name": "cyclin-T1",
    "refseq_ac": [
        {
            "id": "NP_001399552",
            "url": "https://www.ncbi.nlm.nih.gov/protein/NP_001399552",
            "type": "external"
        }
    ],
    "gene_names_uniprotkb": "Ccnt1",
    "gene_names_refseq": "Ccnt1",
    "protein_names_uniprotkb": "Cyclin-T1",
    "protein_names_refseq": "cyclin-T1-like; cyclin-T1",
    "tax_id": 10116,
    "disease": "",
    "pathway": " (R-RNO-112382);  (R-RNO-2173796);  (R-RNO-674695);  (R-RNO-6796648);  (R-RNO-6807505);  (R-RNO-75955);  (R-RNO-9018519)",
    "pathway_count": 7,
    "publication_count": 1,
    "publication_id_list": "29393594",
    "function": "Regulatory subunit of the cyclin-dependent kinase pair (CDK9/cyclin-T1) complex, also called positive transcription elongation factor B (P-TEFb), which facilitates the transition from abortive to productive elongation by phosphorylating the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNA Pol II). Required to activate the protein kinase activity of CDK9: acts by mediating formation of liquid-liquid phase separation (LLPS) that enhances binding of P-TEFb to the CTD of RNA Pol II., [UniProtKB, UniProtKB]",
    "predicted_glycosites": 1,
    "predicted_n_glycosites": 0,
    "predicted_o_glycosites": 1,
    "mined_glycosites": 0,
    "mined_n_glycosites": 0,
    "mined_o_glycosites": 0,
    "reported_n_glycosites": 0,
    "reported_o_glycosites": 0,
    "reported_n_glycosites_with_glycan": 0,
    "reported_o_glycosites_with_glycan": 0,
    "total_reported_n_glycosites": 0,
    "total_reported_o_glycosites": 0,
    "total_n_glycosites": 0,
    "total_o_glycosites": 1,
    "reported_fully_resolved_glycans": 0,
    "reported_phosphosites": 0,
    "reported_mutagensis": 0,
    "reported_glycation": 0,
    "reported_snv": 0,
    "reported_interactions": 0,
    "missing_score": 10000,
    "biomarker_type": "",
    "glycan_count": 0,
    "disease_count": 0,
    "glyco_site_count": 1,
    "binding_glycan_count": 0,
    "secondary_ac_list": "",
    "ec_number_list": [],
    "go_molecular_function": "GO:0003677 DNA binding;GO:0003682 chromatin binding;GO:0019901 protein kinase binding;GO:0000976 transcription cis-regulatory region binding;GO:0070063 RNA polymerase binding",
    "go_cellular_component": "GO:0005634 nucleus;GO:0008024 cyclin/CDK positive transcription elongation factor complex;GO:0070691 P-TEFb complex;GO:0005829 cytosol",
    "go_biological_process": "GO:0045944 positive regulation of transcription by RNA polymerase II;GO:0009410 response to xenobiotic stimulus;GO:0043923 positive regulation by host of viral transcription;GO:0032968 positive regulation of transcription elongation by RNA polymerase II;GO:0032786 positive regulation of DNA-templated transcription, elongation",
    "synthesized_glycan_count": 0,
    "record_id": "A0A0G2JXM2-1",
    "record_type": "protein",
    "filter_code": "0000000.0000101.100000.0000000000001000.00010.001"
}